Presynaptic CaV2.2 (N-type) channels are fundamental for transmitter release across the nervous system. The gene encoding CaV2.2 channels, Cacna1b, contains alternatively spliced exons that originate functionally distinct splice variants (e18a, e24a, e31a and 37a/37b). Alternative splicing of the cassette exon 18a generates two mRNA transcripts (+e18a-Cacna1b and De18a-Cacna1b). In this study, using novel mouse genetic models and in situ hybridization (BaseScope TM ), we confirmed that +e18a-Cacna1b splice variants are expressed in monoaminergic regions of midbrain. We expanded these studies and identified +e18a-Cacna1b mRNA in deep cerebellar cells and spinal cord motor neurons. Furthermore, we determined that +e18a-Cacna1b is enriched in cholecystokinin expressing interneurons. Our results provide key information to understand cell-specific functions of CaV2.2 channels.
INTRODUCTION
Presynaptic CaV2.2 (N-type) channels are key mediators of transmitter release across the nervous system. The calcium that enters through CaV2.2 channels in response to action potentials triggers transmitter release [1, 2] . Cacna1b is a multi-exon gene that encodes the CaVa1 pore-forming subunit of CaV2.2 channels.
The Cacna1b pre-mRNA contains more than 40 exons that are spliced during mRNA maturation [3] . Most Cacna1b exons are constitutively included in the final Cacna1b mRNA, however some are selectively included through alternative splicing (e18a, e24a, e31a and 37a/37b) [4] . Alternative splicing of the Cacna1b pre-mRNA originates splice variants that are translated into CaV2.2 channels with distinct biophysical properties and pharmacological profiles [5, 6] . CaV2.2 splice variants with differences in activation, inactivation and current density [7] [8] [9] , as well as in their response to neurotransmitters and drugs such as GABA and morphine have been previously characterized [10, 11] . Thus, alternative splicing of the Cacna1b pre-mRNA is thought to provide functional diversification to cells that utilize CaV2.2 channels to release neurotransmitter.
Among the alternative spliced exons in the Cacna1b pre-mRNA is the cassette exon 18a (e18a) [12] . Alternative splicing of e18a generates two splice variants, +e18a-Cacna1b (e18a is included) and De18a-Cacna1b (e18a is skipped) (Fig. 1A) .
E18a encodes 21 amino acids within the "synprint" region of the II-III cytoplasmic loop of CaV2.2 (LII-III), an essential region for interaction of CaV2.2 channels with presynaptic proteins [13] [14] [15] . Functionally, +e18a-CaV2.2 channels are more resistant to cumulative inactivation induced by repetitive stimulation and closedstate inactivation than De18a-CaV2.2 channels [9] . Furthermore, +e18a-CaV2.2 channels exhibit larger calcium currents relative to De18a-CaV2.2 channels in both mammalian expression systems and neurons [16] . Despite all of this information, very little is known about the functional role of +18a-Cacna1b and De18a-Cacna1b splice variants in the nervous system.
To understand the functional role of +e18a-Cacna1b and De18a-Cacna1b splice variants, it is necessary to determine their tissue and cell-type expression.
Previous studies have shed light on this. In the adult nervous system, the abundance of +e18a-Cacna1b mRNA differs among tissues. Higher levels of +e18a-Cacna1b mRNA are observed in dorsal root ganglia, superior cervical ganglia, and spinal cord relative to whole brain [6, 16] . Interestingly, the relative abundance between +e18a-Cacna1b and De18a-Cacna1b mRNAs also differs among brain subregions. Less than 10% of Cacna1b splice variants contain e18a in whole cerebral cortex and hippocampus, whereas 30-60% of Cacna1b splice variants contain e18a in the thalamus, cerebellum, hypothalamus and midbrain [12] . Within the midbrain, ~80%
of Cacna1b splice variants contain e18a in monoaminergic regions including the ventral tegmental area (VTA), substantia nigra (SN), dorsal raphe nuclei (DRN), and locus coeruleus (LC) [17] .
The expression of +e18a-Cacna1b is also cell-specific. +e18a-Cacna1b mRNA is enriched in tyrosine hydroxylase-expressing cells of the SN pars compacta (SNc) and VTA [17] . +e18a-Cacna1b has also been identified in magnocellular neurosecretory cells of hypothalamus and capsaicin-responsive neurons of dorsal root ganglia [7, 18] . The molecular mechanisms underlying the tissue-and cellspecific expression of +e18a-Cacna1b and De18a-Cacna1b mRNAs are beginning to be elucidated. The RNA-binding protein, Rbfox2, is a splicing factor that represses e18a by binding an intronic region upstream of this exon [16, 19] . Rbfox2 expression and activity depend on the cell-type; thus, this would help to explain the cell-specific expression of +e18a-Cacna1b and De18a-Cacna1b [20, 21] .
In this study, we utilized a novel version of in situ hybridization (BaseScope™) and genetic mouse models, to precisely determine the expression of +e18a-Cacna1b in the central nervous system. We generated a mouse model that lacks expression of +e18a-Cacna1b, thereby expresses only the De18a-Cacna1b splice variant (De18a-only). This mouse was used to control for probe specificity in our BaseScope™ experiments. With these new approaches and tools, we confirmed that +e18a-Cacna1b mRNA is expressed in monoaminergic regions (SN, VTA, DRN, and LC). Furthermore, we identified new cell populations that express +e18a-Cacna1b mRNA such as cells of the deep cerebellar nuclei (DCN) and spinal cord motor neurons. Finally, using fluorescence-activated cell sorting (FACS) of genetically identified cell populations coupled to RT-PCR, we found that +e18a-Cacna1b mRNA is more abundant in cholecystokinin expressing interneurons (CCK + INs) relative to Ca2+/calmodulin-dependent protein kinase IIa expressing projection neurons (CaMKIIa + PNs).
MATERIALS AND METHODS

Housing Conditions.
A combination of adult males or females were used in all of our experiments, no association to sex was found in the amount of e18a in Cacna1b in whole brain. Mice were housed with food and water ad libitum in temperature-controlled rooms with a 12 h light/dark cycle. All experimental procedures followed the guidelines of the Institutional Animal Care Committee of the University of New Hampshire.
Mouse lines. C57BL/6 wild-type mice were used in our experiments. Mice lacking e18a or De18a-only (Cacna1b tm4.1Dili ) were back crossed in C57BL/6 (Charles River) background for 6-8 generations, for details on how this mouse line was generated see [16] . To label CCK + INs with tdTomato (tdT), we performed intersectional genetic labeling as previously reported [22, 23] . We utilized CCK-Cre (Cck tm1.1(cre)Zjh /J, Jax:012706) in C57BL/6 background, Dlx5/6-Flpe (Tg(mI56iflpe)39Fsh/J, Jax: 010815) in FVB/NJ background, and Ai65-D (B6;129S-Gt(ROSA)26Sort m65.1(CAG-tdTomato)Hze /J, Jax: 021875) in C57BL/6;I129 background mice.
Using these three mouse lines, we generated a triple transgenic line, CCK-Cre; Dlx5/6-Flpe; Ai65-D (named CCK;Dlx5/6;tdT) as follows: First, CCK-Cre mice were crossed with Dlx5/6-Flpe two times to produce a dual transgenic mouse (homozygous for CCK-Cre and heterozygous for Dlx5/6-Flpe). Next, this dual transgenic mouse line was crossed with homozygous Ai65-D mice. From the resulting offspring, we selected only heterozygous mice for the three alleles. To induce the expression of tdT in PNs, we crossed CaMKIIa-Cre mice (B6.Cg-Tg(Camk2a-cre)T29-1Stl/J, Jax: 005359) in a mixed C57BL6 background with Ai14 mice (B6.Cg-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze /J, Jax: 007914) in C57BL6. The resulting dual transgenic mouse line CaMKIIa;tdT was heterozygous for both alleles.
Genotyping. Conventional toe biopsy was performed on P7-P9 pups.
Genomic DNA was extracted using Phire Animal Tissue Direct kit II (ThermoFisher Scientific, F140WH) according to manufacturer instructions. Next, PCR was performed with AmpliTaq Gold ® 360 mastermix (Thermo Fisher Scientific) using the following conditions: a hot start of 95 0 C for 10 min, followed by 35 cycles (95 0 C, 30 s; 60 0 C, 30 s; 72 0 C, 1 min), and final step of 72 0 C for 7 min. Primers and expected products are shown in Table 1 . Primers were added together to genotype each mouse line.
In situ hybridization (BaseScope™). Mice were deeply anesthetized with
Euthasol (Virbac, 200-071). Next, mice were transcardially perfused with 1x PBS for 10 min and subsequently with 10% neutral buffered formalin (NBF, ~4% formaldehyde) fixative solution (Sigma, HT501128) for 10 min, and then again with 1x PBS for 10 min. Both PBS and NBF were kept on ice during the perfusion. Brain and spinal cord were immediately removed and post-fixated in 10% NBF at 4 0 C for 24 hours. After washing with 1x PBS, tissue was sequentially dehydrated in 15% and 30% sucrose:PBS solutions for at least 18 hours in each sucrose concentration, or until tissue sank to the bottom of the tube. Next, tissue was cryopreserved in optimal cutting temperature compound, or OCT (Fisher, 4585), with isopentane prechilled in dry ice. 12 µm cryosections from brain and spinal cord were collected (Shandon, 77200222) and placed in pre-chilled 15 mm NetwellÔ inserts (Corning, 3478). Sections were allowed to free-float in 1x PBS, and mounted on positively charged microscope slides (VWR, 48311-703) using a paintbrush. After air-drying for 10-20 min, sections were incubated at 60° C in a drying oven for 30 minutes to aid tissue adhesion to the slides. Before in-situ hybridization (ISH), sections were post-fixed in 10% NBF at 4° C for 15 minutes, then dehydrated with 50%, 70%, and two rounds of 100% ethanol for 5 minutes in sequential steps. Slides were air-dried for an additional 5 minutes before incubating with RNAscopeâ hydrogen peroxide solution for 10 minutes (ACD, 322381). Next, sections were washed with milliQ water and transferred to RNAscopeâ Target Retrieval solution preheated to 99° C for 15 minutes (ACD, 322000). Sections were briefly washed with milliQ water, transferred to 100% ethanol for 3 minutes, then placed in drying oven at 60°C for 30 minutes. Sections were isolated with a hydrophobic barrier pen (ACD, 310018) and air-dried overnight at room temperature. Following incubation with RNAscopeâ Protease III for 30 minutes (ACD, 322381) at 40° C in the ACD HybEZÔ Hybridization System (ACD, 310010), sections were exposed to a probe spanning e18 and e18a (BaseScopeÔ Mm-Cacna1b-e18e18a) (ACD, 701151) for 2 hours at 40° C in the ACD HybEZÔ Hybridization System. BaseScopeÔ Detection Reagents AMP 0 -AMP 6 and FastRed (ACD, 322910) were applied according to manufacturer instructions and washed using RNAscopeâ Wash Buffer (ACD, 310091). To visualize nuclei, sections were counterstained in Gill's Hematoxylin I for 2 minutes at RT (American Master Tech, HXGHE). Next, sections were washed with tap water 3 times, briefly transferred to 0.02% ammonia water, and washed again with tap water. Finally, sections were dried at 60° C for 15 minutes and mounted using VectaMountÔ mounting medium (Vector Laboratories, H-5000). Phase contrast images were acquired using an Olympus IX-81 microscope. according to manufacturer instructions. To quantify the relative amount of e18a, PCR was performed using AmpliTaq Gold ® 360 master mix (ThermoFisher Scientific, 4398881) with primers flanking e18a (F: 5'GGCCATTGCTGTGGACAACCTT and R: 5'CGCAGGTTCTGGAGCCTTAGCT) with the following conditions: Hot start at 95 0 C for 10 min, 28 cycles (95 0 C for 30 sec, 60 0 C for 30 sec, 72 0 C for 1 min), a final step of 72 0 C for 7 min. These set of primers quantify +e18a-and De18a-Cacna1b splice variants simultaneously. PCR products were run in 3% agarose gel stained with ethidium bromide, and densitometric analysis was performed using ImageJ [24] . This quantification method has been validated before [16] . To confirm band identity, the two bands were cloned and sequenced. To quantify total mRNA levels for Cacna1b, Glutamate decarboxylase-2 (Gad-2) and cannabinoid receptor 1 (Cnr1), 
RESULTS AND DISCUSSION
Validation of a mouse model to detect +e18a-Cacna1b mRNA in the central nervous system
To determine the localization of +e18a-Cacna1b mRNAs in the central nervous system (CNS), we performed a modality of in situ hybridization (BaseScope™). We used a mouse line with targeted deletion of e18a (De18a-only) to control for probe specificity. In this mouse model, DNA sequences between e18 and e19 (e18-e18a intron, e18a, and e18a-e19 intron) were removed using homologous recombination ( Fig. 1A, [16] ). To confirm deletion of e18a sequence, we performed RT-PCR in whole brain samples from WT and De18a-only mice. We utilized primers flanking e18a to quantify both +18a-and De18a-Cacna1b transcripts. Amplicons for each splice variant were resolved on gel electrophoresis based on size (Fig. 1B) . In WT whole brain samples, we observed two bands, ~290 bp and ~230 bp, corresponding to +18a-and D18a-Cacna1b trasncripts respectively (Fig. 1B, bottom left panel, lanes 1-3). As expected, the upper band was absent in samples from De18a-only mice (Fig. 1B, bottom left panel, lanes 4-6) . Next, we tested if the targeted deletion of e18a alters the overall Cacna1b mRNA levels. We quantified total Cacna1b mRNA using RT-qPCR with a probe that spans the splice junction between two constitutive exons, e45 and e46 (Fig. 1B, top panel) . We found no significant differences in the total amount of Cacna1b mRNA between WT and De18a-only mice (Fold change relative to control ± s.e.m.: WT = 1 ± 0.12, n = 7; e18anull = 0.89 ± 0.18, n = 7. p = 0.61. Two tailed, unpaired, Student's t-test. Fig. 1B, right lower panel). Our results show that the e18a sequence was successfully eliminated from the Cacna1b gene and that this deletion does not alter the total Cacna1b mRNA levels in whole brain. Therefore, this model is ideal to control for the specificity of probes directed to e18a, thereby allowing the localization of +e18a-Cacna1b splice variants in CNS tissue.
+e18a-Cacna1b mRNA is expressed in substantia nigra and ventral tegmental area
In the CNS, expression of Cacna1b is restricted to neurons, however the cellspecific expression of the Cacna1b splice variants has not been fully determined [4] .
Previous studies using microdissections and RT-PCR showed that +e18a-Cacna1b mRNA is abundantly expressed in SN and VTA [17] . Furthermore, +e18a-Cacna1b mRNAs colocalize with tyrosine hydroxylase mRNA in both of these brain areas [17] , suggesting that +e18a-Cacna1b mRNA is enriched in dopaminergic neurons.
Here we confirmed these findings using BaseScope TM with a probe designed against the e18a sequence. Briefly, 'Z' probes containing a short complementary region bind to the e18a sequence. This binding leads to the assembly of a signal amplification system, thereby allowing the detection of short RNA sequences ( Fig.   2A) . In our experiments, we used brain sections from De18a-only mice to control for probe specificity. Red signal indicates presence of +e18a-Cacna1b splice variants, and blue indicates counterstaining with hematoxylin (Hem) ( Fig. 2A) . Each dot detects a single mRNA molecule. We performed BaseScope TM in midbrain sections of WT and De18a-only mice. We compared our BaseScope TM images (Fig. 2B, top panels) to conventional in situ hybridization (ISH) images for the dopaminergic marker, Slc6a3 (dopamine transporter, Dat), from SN and VTA found the Allen Mouse Brain Atlas (Fig. 2B, bottom panels) [26] . We observed that staining for e18a follows a pattern similar to Slc6a3 in the midbrain. No signal for e18a was detected on sections from De18a-only mice (Fig. 2B, bottom panels) . These results confirm previous studies showing that e18a is expressed in SN and VTA regions. It is important to note that we observed +e18a-Cacna1b expression in other cells near VTA and SNc, the identity of these cells is currently unknown. Some cells expressing +e18a-Cacna1b were also observed in SN pars reticulata (SNr)
To our knowledge, antibodies specific for +e18a-CaV2.2 channels are unavailable. This would help to convincingly show that +e18a-CaV2.2 channels are present in dopaminergic neurons. However, our use of BaseScope TM with adequate negative controls shed light on the localization of e18a in the midbrain. Previous results have shown that dopamine release from VTA and SNc heavily relies on CaV2.2 channels [27, 28] . Our studies and mouse models combined with previous functional studies of +e18a-and De18a-CaV2.2 channels in mammalian systems and neurons will enable to propose further studies to unveil a potential role of e18a splicing on dopamine release.
Expression of +e18a-Cacna1b mRNA in dorsal raphe nuclei and locus
coeruleus DRN and LC contain neurons that release serotonin and norepinephrine, respectively. DRN is located ventral to the cerebral aqueduct (AQ) (Fig. 3A, top right   panel) . Prior studies showed that +e18a-Cacna1b mRNA is expressed in DRN and LC [17] . We next performed BaseScope TM in these brain areas. To guide our analysis, we compared images for conventional ISH staining for the serotoninergic marker, Slc6a4 (serotonin transporter, Sert), from the Allen Mouse Brain Atlas (Fig. 3A, top left panel [26] ) to our BaseScope TM staining. Signal for e18a was observed ventral to AQ and followed a pattern similar to Slc6a4, suggesting that +e18a-Cacna1b splice variants are expressed in DRN (Fig. 3A, middle and 
bottom left panels). Sections of
De18a-only mice in a similar area show little to no signal for e18a (Fig. 3A, middle and bottom right panels). Our results show that e18a is present in the DRN, however, further studies are needed to determine the cell-populations within the DRN that express +e18a-Cacna1b mRNA. CaV2.2 channels are involved in the release of serotonin [27] , and CaV2.2-null mice show enhanced aggression that has been linked to the control of serotonin neurons excitability [29] . Our results open the possibility that splicing e18a is linked to the activity of the serotonin system.
To determine if +e18a-Cacna1b mRNA is expressed in LC, we stained sections containing the fourth ventricle (V4) and the central lobule of the cerebellum II (CENT2) (Fig. 3B, top panel) . We found that the signal for +e18a-Cacna1b mRNA is located lateral to V4 (Fig. 3B, middle and bottom panels) . This signal is similar to the pattern of expression for Slc6a2 (norepinephrine transporter, Net) observed in ISH images from the Allen Mouse Brain Atlas [26] (Fig. 3B, top panel) . Our results suggest that e18a is present in LC, as previously reported [17] .
Distribution of +e18a-Cacna1b mRNA in cerebellum
In cerebellum, CaV2.2 channels control the release of neurotransmitter from climbing fibers and parallel fibers synapsing onto Purkinje cells [30] [31] [32] . CaV2.2 channels are also critical for the intrinsic firing of DCN neurons by coupling to calcium-dependent potassium channels [33] . In cerebellum, ~20% of Cacna1b splice variants contain e18a [16] . However, the distribution of +e18a-Cacna1b splice variant in the cerebellum is unknown. Using the well-defined anatomy of cerebellum as landmark, we determined the expression of e18a in this area. In cerebellar cortex, little e18a signal was observed in the Purkinje cell layer (p.c.l.), as well as the molecular and granular layers (m.l. and g.l.) (Fig. 4A, left panel, inset 1) . However, in the DCN, we observed several cell bodies stained for e18a ( Fig. 4A, left panel, inset 2 and 3). Very little signal was detected in cerebellar sections from De18a-only mice ( Fig. 4B, right panel) . Our results provide a framework to test if splicing of e18a influences the firing properties of neuronal populations present in DCN.
Expression of +e18a-Cacna1b in spinal cord
CaV2.2 channels have been previously reported in spinal cord at nociceptive afferents, interneurons and motor neurons [34] . In spinal cord, we have previously shown that e18a-containing splice variants represent ~55% of the Cacna1b pool of transcripts [12] . We next determined the pattern of expression of +e18a-Cacna1b in spinal cord. We found very little signal for e18a in laminae I-III (Fig. 5, top panel, inset 1). By contrast, large cell bodies in ventral areas (lamina IX) of spinal cord contained > 6 red dots, indicating the presence of e18a (Fig. 5, top panel, inset 2) .
Note the absence of e18a signal in spinal cord sections of De18a-only mice (Fig. 5,   bottom panels) . It is well known that dorsal laminae of spinal cord primarily contain neurons that receive sensory inputs from dorsal root ganglia, whereas ventral areas contain circuits that control motor neuron activity. Given that motor neurons in lamina IX have larger cell bodies relative to interneurons [35, 36] , our results suggest that e18a is expressed in motor neurons. However, further studies are needed to determine if +e18a-Cacna1b mRNA is more abundant in motor neurons relative to interneurons of spinal cord. Previous studies have shown that some neuromuscular junctions rely on CaV2.2 channels to release acetylcholine (phrenic nerve-diaphragm), whereas others utilize almost exclusively CaV2.1 (sciatic nervetibialis muscle) [37, 38] . The cell-specific expression of +e18a-Cacna1b mRNA could provide an explanation for this neuromuscular junction-specific role of CaV2.2 channels.
Expression of +e18a-Cacna1b splice variants in hippocampus
The functional role of CaV2.2 channels in controlling neurotransmission has been extensively described in hippocampal synapses. Interestingly, the distribution of Cacna1b splice variants in the hippocampus is unknown. Interneurons reside in stratum radiatum (s.r), whereas PNs are arranged along stratum pyramidale (s.p.) of both CA1 and CA3 regions. Using these anatomical landmarks, we determined the expression of e18a in CA1 and CA3 regions. Signal for +e18a-Cacna1b mRNA was detected in nuclei of s.r. and s.p. Interestingly, only a sub-population of s.r. nuclei showed strong signal for e18a in both regions ( Fig. 6A and 6B, left panels) . In dentate gyrus (DG), interneurons are located in the hilus (h.), whereas granular cells (GC) are localized in the granular cell layer (g.c.l). Here, we observed signal for e18a in several nuclei located in h. and g.c.l. (Fig. 6C) . In sections from De18a-only mice, signal for e18a was absent throughout all regions of hippocampus analyzed ( Fig.   6A-C, right panels) . Based on anatomical landmarks for hippocampus, our results suggest that e18a is broadly distributed among PN, GC and a subpopulation of interneurons in the hippocampus.
+e18a-Cacna1b splice variants are enriched in cholecystokinin expressing interneurons
CaV2.2 channels, together with CaV2.1 and CaV2.3, control transmitter release of excitatory terminals [39] . CaV2.2 channels also couple to calcium-dependent potassium channels in PNs, thereby controlling neuronal firing [40] . Furthermore, CCK + INs in s.r. of CA1 and CA3, and h. of DG heavily rely on CaV2.2 channels to release GABA [41] . To determine the cell-specific pattern of expression for +e18a-Cacna1b mRNA, we compared the relative amounts of +e18a-and De18a-Cacna1b [43] [44] [45] , therefore to further validate our cell sorting, we compared the levels of Cnr1 mRNA between CCK + INs and CaMKIIa + PNs. We found that CCK + INs express significantly higher levels of Cnr1 than CaMKIIa + PNs (% fold change, mean ± S.E. CCK + IN = 102 ± 23.0, n = 7, CaMKIIa + PNs = 1.0 ± 0.30, n = 8, p = 0.0002, Student's ttest. Fig. 7C, right panel) . Taken together our results strongly suggest that +e18a-Cacna1b pre-mRNA is expressed at higher levels in CCK + INs relative to CaMKIIa + PNs. CCK + INs are linked to mood disorders [46, 47] , express relatively high levels of the cannabinoid receptor protein (CB1R) [48] , and contribute to the behavioral tolerance of tetrahydrocannabinol [49] . Given that CB1R agonists downregulate CaV2.2 channels to inhibit GABA release in CCK + INs, our findings suggest an anatomical link between e18a splicing in Cacna1b and the effects of CB1R agonists of transmitter release. Furthermore, CCK + INs in hippocampus show robust asynchronous release and spontaneous release that relies on CaV2.2 channels [41] .
Due to the slower inactivation rates and positive shift in voltage-dependent inactivation of +18a-CaV2.2 channels relative to D18a-CaV2.2 channels, it is possible that inclusion of e18a in this neuronal type enhances asynchronous and spontaneous release. 
